Overview

BI 443651 Methacholine Challenge

Status:
Completed

Trial end date:
2018-02-21

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to investigate safety and tolerability of three consecutive administrations, 12 hours apart, at three different dose-levels of BI 443651 administered via oral inhalation in male and female mild asthmatic subjects after a bolus methacholine challenge.

Phase:

Phase 1

Details

Lead Sponsor:

Boehringer Ingelheim

Treatments:

Methacholine Chloride